Mink TherapeuticsINKT
13F holders, Q2 2026 (June 30)27holders +4
7new positions
3sold out
1famous investor
$11.69avg. 13F price*
At the end of Q2 2026, 27 institutions reported holding Mink Therapeutics Inc. (INKT) in their 13F filings, up 4 from Q1 2026. 7 opened new positions and 3 sold out. The largest holders were Vanguard Capital Management LLC ($803K), DNB Asset Management AS ($645K) and Longbow Finance SA ($195K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Mink Therapeutics Inc.
- CUSIP
- 603693201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $855K |
| Exits | 3 | $3K |
All 13F filers, Q1 2026 → Q2 2026: 89,979 shares bought and 12,388 shares sold, net +77,591 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Vanguard Capital Management LLC | 0.00% | Add +15.7% | 68,660 | $803K |
| DNB Asset Management AS | 0.00% | New | 55,142 | $645K |
| Longbow Finance SA | 0.02% | No change | 16,667 | $195K |
| Geode Capital Management, LLC | 0.00% | Reduce -10.2% | 15,573 | $182K |
| Citadel Advisors | 0.00% | New | 15,440 | $180K |
| BlackRock, Inc. | 0.00% | Add +115.7% | 13,382 | $156K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 8,287 | $97K |
| UBS Group AG | 0.00% | Reduce -67.9% | 4,885 | $57K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 2,000 | $23K |
| US Bancorp \de | 0.00% | New | 1,995 | $23K |
| Paladin Partners, LLC | 0.01% | No change | 1,000 | $12K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 500 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +170.5% | 422 | $5K |
| Osaic Holdings, Inc. | 0.00% | Add +11600.0% | 117 | $1K |
| Morgan Stanley | 0.00% | Add +8.7% | 113 | $1K |
| Covestor Ltd | 0.00% | No change | 119 | $1K |
| Barclays PLC | 0.00% | New | 24 | $281 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 18 | $210 |
| Caitong International Asset Management Co., Ltd | 0.00% | Add +80.0% | 18 | $210 |
| Game Plan Financial Advisors, LLC | 0.00% | No change | 16 | $187 |
| Clearstead Advisors, LLC | 0.00% | No change | 14 | $164 |
| BNP Paribas Financial Markets | 0.00% | Reduce -18.8% | 13 | $152 |
| JPMorgan Chase & Co. | 0.00% | No change | 9 | $107 |
| Key Financial Inc | 0.00% | No change | 4 | $47 |
| Wells Fargo & Company | 0.00% | New | 2 | $23 |
| LifeSteps Financial, Inc. | 0.00% | New | 2 | $23 |
| Jones Financial Companies LLLP | 0.00% | No change | 1 | $12 |
"% of holder's portfolio" is INKT's weight in each manager's 13F, not the share of Mink Therapeutics Inc. the manager owns.